We demonstrated that, regardless of the IgA isotype, prophylactically administered FliD-reactive SIgA can enhance Campylobacter clearance at early stages post-infection, dramatically reducing the levels of inflammation markers associated with epithelial damage and polymorphonuclear (PMN) cells infiltration. The gene discussed is CD79A; the disease is infection.